 Leuven, BE, Boston, MA, US April 13th, 2021 7.30 AM CET Oxurion NV Euronext Brussels: OXUR, a biopharmaceutical company developing next generation standard-of-care ophthalmic therapies, with a clinical stage portfolio in retinal vascular disorders, today announces that Grace Chang, M.D., Ph.D., Chief Medical Officer CMO of Oxurion, will be presenting at the Wet AMD and DME Drug Development Summit, taking place from April 13 to 15, 2021. 